Metabolic Syndrome and Its Biochemical Implications: Insights into Early Detection
Abstract
Metabolic syndrome (MetS) is a multifaceted clinical condition characterized by a cluster of metabolic abnormalities, including central obesity, insulin resistance, hypertension, dyslipidemia, and glucose intolerance. It significantly increases the risk of developing cardiovascular diseases and type 2 diabetes mellitus. The biochemical implications of MetS are profound, involving alterations in lipid metabolism, chronic low-grade inflammation, oxidative stress, and hormonal imbalances. These disturbances are often reflected in biomarkers such as elevated fasting glucose, increased triglycerides, decreased HDL cholesterol, high levels of C-reactive protein (CRP), and insulin resistance markers like HOMA-IR. Early detection of MetS is crucial for preventing its progression and associated complications. Biochemical screening provides a valuable tool for identifying at-risk individuals before clinical symptoms become evident. Recent research emphasizes the role of adipokines, pro-inflammatory cytokines (such as TNF-α and IL-6), and oxidative stress markers as early indicators of metabolic dysfunction. Additionally, advances in genomics and metabolomics have enhanced our understanding of the pathophysiological mechanisms underlying MetS, offering promising avenues for personalized intervention strategies. This review highlights the importance of integrating biochemical markers in routine clinical assessments for early identification of MetS. Understanding the interplay between metabolic pathways and biochemical alterations can aid in developing more targeted therapeutic approaches. Ultimately, early biochemical diagnosis, combined with lifestyle modification and pharmacological interventions, may reduce the global burden of metabolic syndrome and its life-threatening sequelae.
References
K. Srikanthan, A. Feyh, H. Visweshwar, J. I MD Shapiro et al., "Systematic Review of Metabolic Syndrome Biomarkers: A Panel for Early Detection, Management, and Risk Stratification in the West Virginian Population," 2016.
X. Liang, B. Or, M. F. Tsoi, and C. L. Cheung, "Prevalence of metabolic syndrome in the United States national health and nutrition examination survey 2011–18," Postgraduate Medical Journal, 2023.
H. Chen, X. Zheng, X. Zong, Z. Li, N. Li, J. Hur, and C. D. L. Fritz, "Metabolic syndrome, metabolic comorbid conditions and risk of early-onset colorectal cancer," *Gut*, vol. 70, no. 4, pp. 678-685, 2021.
C. Yang, X. Jia, Y. Wang, J. Fan et al., "Trends and influence factors in the prevalence, intervention, and control of metabolic syndrome among US adults, 1999–2018," BMC geriatrics, 2022.
P. Rattan, D. D. Penrice, J. C. Ahn, A. Ferrer, et al., "Inverse association of telomere length with liver disease and mortality in the US population," Hepatology, vol. 76, no. 4, pp. 1002-1012, 2022.
C. W. Hicks, D. Wang, K. Matsushita, et al., "Peripheral neuropathy and all-cause and cardiovascular mortality in US adults: a prospective cohort study," *Annals of Internal Medicine*, vol. 2021.
S. Lim, J. W. Kim, and G. Targher, "Links between metabolic syndrome and metabolic dysfunction-associated fatty liver disease," Trends in Endocrinology & Metabolism, 2021.
N. Ahluwalia, R. Raghavan, G. Zhang, et al., "Vitamin D status and prevalence of metabolic syndrome by race and Hispanic origin in US adults: findings from the 2007–2014 NHANES," The American Journal of Clinical Nutrition, 2023.
J. Hong, R. Zhang, H. Tang, S. Wu, and Y. Chen, “... in predicting cardiovascular diseases incidence among populations with cardiovascular-kidney-metabolic syndrome stages 0–3: a nationwide prospective cohort,” Cardiovascular, vol. 2025, Springer.
A. Šoštarič, B. Jenko, N. Rotovnik Kozjek, D. Ovijač et al., "Detection of metabolic syndrome burden in healthy young adults may enable timely introduction of disease prevention," 2019.
K. Shin, Y. M. Bae, and H. Kweon, "Non-Invasive Multichannel Vagus Nerve Stimulator With Heart Rate Measurement for Closed-Loop Control," 2025 International Conference on …, 2025.
W. K. Chan, K. H. Chuah, R. B. Rajaram, et al., "Metabolic dysfunction-associated steatotic liver disease (MASLD): a state-of-the-art review," *Journal of Metabolic Syndrome*, 2023.
S. Alfihed, M. Majrashi, M. Ansary, N. Alshamrani, "Non-invasive brain sensing technologies for modulation of neurological disorders," Biosensors, 2024.
K. Wang, S. Margolis, J. M. Cho, S. Wang, et al., "Non‐Invasive Detection of Early‐Stage Fatty Liver Disease via an On‐Skin Impedance Sensor and Attention‐Based Deep Learning," *Advanced*, vol. 2024, Wiley Online Library.
Y. Shi and W. Wu, "Multimodal non-invasive non-pharmacological therapies for chronic pain: mechanisms and progress," BMC medicine, 2023.
A. Kandwal, Y. D. Sharma, R. Jasrotia, C. C. Kit, "A comprehensive review on electromagnetic wave based non-invasive glucose monitoring in microwave frequencies," Heliyon, 2024.
S. Kumari, D. K Kataria, S. Kumari, R. Rani et al., "Metabolic Syndrome Frequency in Type 2 Diabetics Using International Diabetes Federation (IDF) Criteria Analysis," 2024.
M. Nwankwo, C. J. Okamkpa, and B. Danborno, "Comparison of diagnostic criteria and prevalence of metabolic syndrome using WHO, NCEP-ATP III, IDF and harmonized criteria: A case study from urban southeast …," Diabetes & Metabolic Syndrome, vol. XX, no. XX, pp. XX-XX, 2022.
E. Rivadeneyra-Domínguez and J. J. Díaz-Vallejo, "A Comparative Study of Metabolic Syndrome Using NCEP—ATP III and IDF Criteria in Children and Its Relationship with Biochemical Indicators in Huatusco, Veracruz," Children, 2023.
S. O. Adil, K. I. Musa, F. Uddin, A. Khan, I. Khan, "Prevalence of undiagnosed metabolic syndrome using three different definitions and identifying associated risk factors among apparently healthy adults in Karachi," Archives of Public Health, vol. 2024, Springer, 2024.
Y. Huang, L. Zhang, Z. Wang, X. Wang, Z. Chen, and L. Shao, "The prevalence and characteristics of metabolic syndrome according to different definitions in China: a nationwide cross-sectional study, 2012–2015," BMC Public Health, vol. 22, no. 1, 2022.
Z. Jamali, F. Ayoobi, Z. Jalali, R. Bidaki, and M. A. Lotfi, "Metabolic syndrome: a population-based study of prevalence and risk factors," *Scientific Reports*, 2024.
M. Kazamel, A. M. Stino, and A. G. Smith, "Metabolic syndrome and peripheral neuropathy," Muscle & Nerve, 2021.
D. J. Hoffman, T. L. Powell, and E. S. Barrett, "Developmental origins of metabolic diseases," *Physiological Reviews*, vol. 101, no. X, pp. Y-Z, 2021.
F. Alkhulaifi and C. Darkoh, "Meal timing, meal frequency and metabolic syndrome," Nutrients, 2022.
J. Zhou, X. Meng, L. Deng, and N. Liu, "Non-linear associations between metabolic syndrome and four typical heavy metals: data from NHANES 2011–2018," Chemosphere, 2022.
A. Bovolini, J. Garcia, M. A. Andrade, "Metabolic syndrome pathophysiology and predisposing factors," *International Journal of...*, 2021.
O. Tabatabaei-Malazy, S. Saeedi Moghaddam, et al., "A nationwide study of metabolic syndrome prevalence in Iran; a comparative analysis of six definitions," *PloS One*, vol. 16, no. 4, 2021.
D. Srinivas Kakkilaya Bevinje, "Insulin Resistance: From Theory To Practice," 2006.
E. Succurro, P. Vizza, A. Papa, F. Cicone et al., "Metabolic Syndrome Is Associated With Impaired Insulin-Stimulated Myocardial Glucose Metabolic Rate in Individuals With Type 2 Diabetes: A Cardiac Dynamic (18)F-FDG-PET Study," 2022.
C. Reisinger and B. N. Nkeh-Chungag, "The prevalence of pediatric metabolic syndrome—A critical look on the discrepancies between definitions and its clinical importance," *Journal of Obesity*, vol. 2021, 2021.
N. Mili, S. A. Paschou, D. G. Goulis, and M. A. Dimopoulos, "Obesity, metabolic syndrome, and cancer: pathophysiological and therapeutic associations," Endocrine, vol. 74, no. 1, pp. 1-12, 2021.
P. Karra, M. Winn, S. Pauleck, A. Bulsiewicz‐Jacobsen, et al., "Metabolic dysfunction and obesity‐related cancer: beyond obesity and metabolic syndrome," 2022.
A. Tylutka, B. Morawin, Ł. Walas, M. Michałek, A. Gwara, et al., "Assessment of metabolic syndrome predictors in relation to inflammation and visceral fat tissue in older adults," *Scientific Reports*, 2023.
J. He, Y. Lai, J. Yang, Y. Yao, Y. Li, and W. Teng, "The relationship between thyroid function and metabolic syndrome and its components: a cross-sectional study in a Chinese population," *Frontiers in*, vol. 2021.
S. M. Alwash, H. D. McIntyre, and A. Mamun, "The association of general obesity, central obesity and visceral body fat with the risk of gestational diabetes mellitus: Evidence from a systematic review and meta …," Obesity Research & Clinical Practice, 2021.
G. Mocciaro, S. D’Amore, B. Jenkins, R. Kay et al., "Lipidomic Approaches to Study HDL Metabolism in Patients with Central Obesity Diagnosed with Metabolic Syndrome," 2022.
Y. He, J. Wang, J. Wang, R. Qiu, S. Wang, "Influence of Central Obesity on Associations Between Physical Activity, Sitting Time, and Metabolic Syndrome Among Middle-Aged and Older Adults in Urban China," Obesity, 2024.
A. Crispo, L. S. A. Augustin, A. Luongo, C. Calderaio, et al., "Central obesity, body mass index, metabolic syndrome and mortality in Mediterranean breast cancer patients," *Scientific Reports*, vol. 13, no. 1, 2023.
I. Trestini, I. Sperduti, A. Caldart, C. Bonaiuto, E. Fiorio, et al., “Adherence to dietary guidelines, anthropometric measures and serum metabolic biomarkers in early-stage breast cancer patients: a prospective interventional study,” *The Breast*, vol. 2021, Elsevier.
H. Zhao, G. Zhu, T. Zhu, B. Ding, A. Xu, S. Gao, Y. Chao, "Gut microbiome and metabolism alterations in schizophrenia with metabolic syndrome severity," BMC Psychiatry, vol. 24, 2024.
G. Fahed, L. Aoun, M. Bou Zerdan, S. Allam, "Metabolic syndrome: updates on pathophysiology and management in 2021," *International Journal of …*, 2022.
Y. Long, C. Mao, S. Liu, Y. Tao et al., "Epigenetic modifications in obesity‐associated diseases," MedComm, 2024.
S. M. Hashemi, M. Kheirandish, and S. Rafati, "The association between neutrophil and lymphocyte to high-density lipoprotein cholesterol ratio and metabolic syndrome among Iranian population, finding from …," Lipids in Health and Disease, vol. 2024, Springer.
D. Ambroselli, F. Masciulli, E. Romano, G. Catanzaro, "New advances in metabolic syndrome, from prevention to treatment: the role of diet and food," Nutrients, 2023.
S. Akter, H. Akhter, H. S. Chaudhury, M. D. H. Rahman, "Dietary carbohydrates: Pathogenesis and potential therapeutic targets to obesity‐associated metabolic syndrome," 2022.
Hamad, Anas Abdullah, Hamssa Majid Mustafa, and Osama A. Mohsein. "Detection of the levels of immune cytokines (IL4, IL5, TNF-α) in school-age and preschoolers with an Ascaris lumbricoides infection." Journal of Parasitic Diseases 48.4 (2024): 782-787.
A. T Kraja, M. A Province, D. Arnett, L. Wagenknecht et al., "Do inflammation and procoagulation biomarkers contribute to the metabolic syndrome cluster?," 2007.
L. M. A. Balderas-Peña and D. Sat-Muñoz, "Influence of chronic low-grade inflammation (obesity) on the systemic inflammatory response," Inflammatory, 2023.
M. Cifuentes, H. E. Verdejo, P. F. Castro, "Low-grade chronic inflammation: a shared mechanism for chronic diseases," 2025.
A. Litwiniuk, W. Bik, M. Kalisz, "Inflammasome NLRP3 potentially links obesity-associated low-grade systemic inflammation and insulin resistance with Alzheimer's disease," *International Journal of …*, vol. 2021.
Lateef, Diyar, Nesreen Nasser, and Osama Mohsein. "The relationships between Aplein, Vaspin and thyroid hormone levels in obese diabetic and non-diabetic women." Journal of Experimental and Clinical Medicine 41.2 (2024): 239-245.
G. T. Ruan, H. L. Xie, Y. Z. Gong, Y. Z. Ge, Q. Zhang, Z. W. Wang, et al., "Prognostic importance of systemic inflammation and insulin resistance in patients with cancer: a prospective multicenter study," BMC Cancer, vol. 22, no. 1, 2022.
V. Boccardi, F. Mancinetti, M. Baroni, R. Cecchetti, et al., "Metabolic score for insulin resistance (METS-IR) and circulating cytokines in older persons: the role of gender and body mass index," Nutrients, 2022.
J. H. Wu, X. L. Liu, N. Lu, R. Wang, F. Z. Yin, and Q. Lu, "… -corrected definition of metabolic syndrome is a simple and effective method for identifying insulin resistance and low-Grade inflammation in adolescents: metabolic …", Clinical, 2023.
G. B. Carvalho, P. N. Brandão-Lima, T. B. Payolla, et al., "Circulating MiRNAs are associated with low-grade systemic inflammation and leptin levels in older adults," Inflammation, vol. 2023, Springer.
P. Wang, X. Guo, Y. Zhou, Z. Li, S. Yu, and Y. Sun, "Monocyte-to-high-density lipoprotein ratio and systemic inflammation response index are associated with the risk of metabolic disorders and cardiovascular diseases," *Frontiers in...,* 2022.
Faisal, Ahmed Nassir, Abbas Mohsin Abbas, and Osama A. Mohsein. "Histological and cytokine-based biomarkers in the early diagnosis of cancer." Indonesian Journal on Health Science and Medicine 2.2 (2025): 10-21070.
B. Biondi, "Subclinical hypothyroidism in patients with obesity and metabolic syndrome: a narrative review," Nutrients, 2023.
Y. Hong, R. Ullah, J. B. Wang, and J. F. Fu, "Trends of obesity and overweight among children and adolescents in China," World Journal of Pediatrics, 2023.
M. Litwin and Z. Kułaga, "Obesity, metabolic syndrome, and primary hypertension," Pediatric Nephrology, 2021.
M. Kivimäki, A. Bartolomucci, and I. Kawachi, "The multiple roles of life stress in metabolic disorders," Nature Reviews Endocrinology, 2023.
E. Haverinen, M. F. Fernandez, V. Mustieles, "Metabolic syndrome and endocrine disrupting chemicals: an overview of exposure and health effects," *International Journal of …*, 2021.
S. Sarma, S. Sockalingam, and S. Dash, "Obesity as a multisystem disease: Trends in obesity rates and obesity‐related complications," Obesity and Metabolism, 2021.
A. E. Brown and M. Walker, "Genetics of Insulin Resistance and the Metabolic Syndrome," 2016.
Mustafa, Hamssa M., Anas Abdullah Hamad, and Osama A. Mohsein. "Investigating specific calprotectin and immunological markers associated with intestinal infections caused by Entamoeba histolytica." Iranian Journal of Veterinary Medicine 18.4 (2024): 535-544.
A. Kotowska‐Zimmer and M. Pewinska, "Artificial miRNAs as therapeutic tools: Challenges and opportunities," Wiley Interdisciplinary Reviews: RNA, vol. 12, no. 1, 2021.
N. D. Germain, W. K. Chung, and P. D. Sarmiere, "RNA interference (RNAi)-based therapeutics for treatment of rare neurologic diseases," Molecular Aspects of Medicine, 2023.
Z. Fu, X. Zhang, X. Zhou, U. Ur-Rehman, M. Yu, and H. Liang, "In vivo self-assembled small RNAs as a new generation of RNAi therapeutics," Cell Research, vol. 31, no. 6, pp. 617-619, 2021.
M. A. Monty, M. A. Islam, X. Nan, J. Tan, et al., "Emerging role of RNA interference in immune cells engineering and its therapeutic synergism in immunotherapy," *British Journal of…*, 2021.
Adnan, Azher, Zainab Mohammed Farhan, and Osama A. Mohsein. "Understanding the link between diabetes mellitus and fatty liver disease: A narrative review." Int J Chem Stud 12.4 (2024): 40-48.
M. Isenmann, M. J. Stoddart, R. Schmelzeisen, and C. Gross, "Basic principles of RNA interference: nucleic acid types and in vitro intracellular delivery methods," Micromachines, vol. 2023.
Qassim Mohammad, Sarmad, Abdullah Khazal Mohsen, and Idriss Saleh Jalil. "Assessing the Prevalence of Bacterial Vaginosis among Infertile Women in Thi-Qar Province, Iraq." Infection Epidemiology and Microbiology 10.4 (2024): 287-296.
T. Wang, Y. Yao, X. Hu, and Y. Zhao, "Message in hand: the application of CRISPRi, RNAi, and LncRNA in adenocarcinoma," Medical Oncology, 2022.
C. N. Hsu, C. Y. Hou, W. H. Hsu, and Y. L. Tain, "Early-Life Origins of Metabolic Syndrome: Mechanisms and Preventive Aspects," 2021.
E. Lemche, O. S. Chaban, and A. V. Lemche, "Neuroendocrinological and Epigenetic Mechanisms Subserving Autonomic Imbalance and HPA Dysfunction in the Metabolic Syndrome," 2016.
S. V. Seal and J. D. Turner, "The 'Jekyll and Hyde'of gluconeogenesis: early life adversity, later life stress, and metabolic disturbances," International Journal of Molecular Sciences, 2021.
T. Kobiec, C. Mardaraz, N. Toro-Urrego, "Neuroprotection in metabolic syndrome by environmental enrichment. A lifespan perspective," Frontiers in ..., 2023.
Hilo, Zainab Qassim Mohammed, Aswan Mahmood, and Osama A. Mohsein. "Genomic Insights into Staphylococcus aureus: Mechanisms of Antibiotic Resistance and Virulence Gene Expression." European Journal of Ecology, Biology and Agriculture 1.5 (2024): 29-48.
S. N. Doan, "Allostatic load: Developmental and conceptual considerations in a multi‐system physiological indicator of chronic stress exposure," Developmental psychobiology, 2021.
L. K. McEvoy, J. Bergstrom, X. Tu, A. C. Garduno, et al., “Alcohol use is associated with reduced cardiovascular risk in middle-aged men independent of health, behavior, psychosocial, and earlier life factors,” Nutrients, 2022.
Ismail, Mona Adel, et al. "Exploring the Genetic Variability of Escherichia coli Pathotypes in Urinary Tract Infections: Implications for Diagnostics and Treatment." Cent Asian J Med Nat Sci 6.1 (2024): 179-191.
S. L. Chia, S. Kapoor, C. Carvalho, et al., "Mast cell ontogeny: From fetal development to life‐long health and disease," Immunological Reviews, vol. 2023, Wiley Online Library.
O. Ramos-Lopez, F. I. Milagro, J. I. Riezu-Boj, and others, "Epigenetic signatures underlying inflammation: An interplay of nutrition, physical activity, metabolic diseases, and environmental factors for personalized nutrition," Inflammation, vol. 2021, Springer.
M. Alemany, "Do the Interactions between Glucocorticoids and Sex Hormones Regulate the Development of the Metabolic Syndrome?," 2012. ncbi.nlm.nih.gov
E. Gesteiro, A. Megía, A. Guadalupe-Grau, et al., "Early identification of metabolic syndrome risk: A review of reviews and proposal for defining pre-metabolic syndrome status," *Nutrition, Metabolism & Cardiovascular Diseases*, vol. 31, no. 1, pp. 1-10, 2021.
Abdulmuttaleb, Nabaa Azhar, Mohammed Qasim Mohammed, and Osama Akram Mohsein. "Exploring the Connection Between Inflammatory Cytokines, Hypertension, and Diabetes in Angina Patients." Cytokines 14.15 (2024): 16.
M. Trigka and E. Dritsas, "Predicting the occurrence of metabolic syndrome using machine learning models," Computation, 2023.
J. V. Torregrosa, J. Bover, M. R. Portillo, E. G. Parra, et al., "Recommendations of the Spanish Society of Nephrology for the management of mineral and bone metabolism disorders in patients with chronic kidney …," Nefrología (English Edition), vol. 43, no. 2, pp. 123-135, 2023.
J. Salvador, G. Gutierrez, M. Llavero, J. Gargallo, "Endocrine disorders and psychiatric manifestations," in *Journal of Endocrinology and Systemic Diseases*, vol. 2021, Springer.
A. Corsello, R. M. Paragliola, and R. Salvatori, "Diagnosing and treating the elderly individual with hypopituitarism," in *Endocrine and Metabolic*, 2024, Springer.
Abd-Alwahab, Hadeel S., Zainab Mohammed Farhan, and Nesreen Ahmed. "Estimation of thyroid hormone and adipocytokine levels in men with obesity and type 2 diabetes in Thi-Qar Governorate."
A. M. Alshehri, "Metabolic syndrome and cardiovascular risk," 2010.
IJ Neeland, S. Lim, A. Tchernof, A. Gastaldelli, "Metabolic syndrome," Reviews Disease, vol. 2024.
Taha, Ruqayah Qubtan, et al. "Bacterial aetiologies of otitis media and their antimicrobial susceptibility in ear swab culture." IJBS 6.1 (2024): 94-99.
M. D. Sekgala, M. Opperman, B. Mpahleni, and others, "Anthropometric indices and cut-off points for screening of metabolic syndrome among South African taxi drivers," Frontiers in…, vol. 2022.
Al-Ani, Asma A. Gayed, and Nagham S. Turkey Al-Awadie. "Continuous Flow Injection: Turbidimetric (0-180) Determination of Chlorpheniramine Maleate Using Five Snow White LEDs as a Source of Irradiation and Single Solar Cells as an Energy Transducer." (2025).
Almohaisen, Farooq LJ, et al. "Cytokines' Impact on Postpartum Hair Loss After First C-Section in Women 28-38: Dampak Sitokin terhadap Kerontokan Rambut Pasca Persalinan Setelah Operasi Caesar Pertama pada Wanita 28-38." Indonesian Journal on Health Science and Medicine 2.2 (2025): 10-21070.
W. Li, X. Qiu, H. Ma, and Q. Geng, "Incidence and long-term specific mortality trends of metabolic syndrome in the United States," Frontiers in Endocrinology, 2023.
S. M. Mohamed, M. A. Shalaby, R. A. El-Shiekh, "Metabolic syndrome: risk factors, diagnosis, pathogenesis, and management with natural approaches," Food Chemistry, vol. 2023, Elsevier.
M. Grabia, R. Markiewicz-Żukowska, and K. Socha, "Prevalence of metabolic syndrome in children and adolescents with type 1 diabetes mellitus and possibilities of prevention and treatment: a systematic review," Nutrients, 2021.
Abbas, Abbas Mohsin, Iman H. Shewael, and Osama A. Mohsein. "Lipoprotein Ratios as Biomarkers for Assessing Chronic Atherosclerosis Progression." Academia Open 10.1 (2025): 10-21070.
S. Chackrewarthy, D. Gunasekera, A. Pathmeswaren, C. N. Wijekoon et al., "A Comparison between Revised NCEP ATP III and IDF Definitions in Diagnosing Metabolic Syndrome in an Urban Sri Lankan Population: The Ragama Health Study," 2013.
L. Dilworth, A. Facey, and F. Omoruyi, "Diabetes mellitus and its metabolic complications: the role of adipose tissues," *International Journal of Molecular*, vol. 2021.
Abbas, Zainab Khamis, et al. "Immunological biomarkers and their role in the diagnosis and prognosis of leishmaniasis: A case–control study." Tropical Parasitology 15.1 (2025): 33-41.
A. Noce, M. Di Lauro, F. Di Daniele, et al., "Natural bioactive compounds useful in clinical management of metabolic syndrome," Nutrients, 2021.
Faisal, A. N., and O. A. Mohsein. "Comprehensive Study on Gynecomastia: Clinical Features, Pathophysiology, Morphologic, and Microscopic Features." Central Asian Journal of Medical and Natural Science 6.2 (2025): 775-789.
S. M. Grundy, H. Bryan Brewer, J. I. Cleeman, S. C. Jr. Smith et al., "Definition of Metabolic Syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association Conference on Scientific Issues Related to Definition," 2004.
A. N. Couto, H. H. Pohl, M. E. Bauer, and C. H. A. Schwanke, "Accuracy of the triglyceride-glucose index as a surrogate marker for identifying metabolic syndrome in non-diabetic individuals," Nutrition, 2023.
Hussein, Abdulhakeem Dahham, et al. "Emerging biomarkers in cancer detection and prognosis: A comprehensive review." International Journal of Immunology 7.1 (2025): 01-12.
W. Li, D. Chen, Y. Peng, and Z. Lu, "Association between metabolic syndrome and mortality: prospective cohort study," *JMIR Public Health and Surveillance*, vol. 2023.
D. Gemeda, E. Abebe, and A. Duguma, "Metabolic syndrome and its associated factors among type 2 diabetic patients in southwest Ethiopia, 2021/2022," Journal of Diabetes, vol. XX, no. XX, pp. XX-XX, 2022.
K. Ma, H. Liu, L. Guo, J. Li, Y. Lei, X. Li, and L. Sun, "Comparison of metabolic syndrome prevalence and characteristics using five different definitions in China: a population-based retrospective study," Frontiers in Public Health, 2024.
Abdulhussien, Adeeb Abdulally, Zainab M. Farhan, and Osama A. Mohsein. "The Clinico-Pathological Role of Horizontal Gene Transfer in the Ability of Pseudomonas Aeruginosa to Cause Disease in Lung Tissue." European Journal of Medical and Health Research 3.1 (2025): 27-34.
K. Ueno, H. Kaneko, Y. Suzuki, A. Okada, "Metabolic syndrome and cardiovascular disease in cancer survivors," *Journal of Cachexia*, 2024.
N. S. Nurmohamed, J. P. Belo Pereira, et al., "Targeted proteomics improves cardiovascular risk prediction in secondary prevention," *European Heart Journal*, 2022.
D. Crosby, S. Bhatia, K. M. Brindle, L. M. Coussens, C. Dive, "Early detection of cancer," Science, vol. 2022.
E. M. Stoffel, R. E. Brand, and M. Goggins, "Pancreatic cancer: changing epidemiology and new approaches to risk assessment, early detection, and prevention," Gastroenterology, 2023.
R. C. Fitzgerald, A. C. Antoniou, L. Fruk, and N. Rosenfeld, "The future of early cancer detection," Nature medicine, 2022.
Hussein, Abdulhakeem Dahham, et al. "Emerging biomarkers in cancer detection and prognosis: A comprehensive review." International Journal of Immunology 7.1 (2025): 01-12.
A. Haider, N. H. Elghazawy, A. Dawoud, et al., "Translational molecular imaging and drug development in Parkinson's disease," *Molecular Imaging*, vol. 2023, Springer.
W. Wu, Y. Cheng, H. Zhou, C. Sun et al., "The SARS-CoV-2 nucleocapsid protein: its role in the viral life cycle, structure and functions, and use as a potential target in the development of vaccines and …," Virology journal, 2023.
W. K. Self and D. M. Holtzman, "Emerging diagnostics and therapeutics for Alzheimer disease," Nature medicine, 2023.
Adnan, Azher, Zainab Mohammed Farhan, and Osama A. Mohsein. "Understanding the link between diabetes mellitus and fatty liver disease: A narrative review." Int J Chem Stud 12.4 (2024): 40-48.
L. Broderick and H. M. Hoffman, "IL-1 and autoinflammatory disease: biology, pathogenesis and therapeutic targeting," Nature Reviews Rheumatology, 2022.
C. E. Kosmas, S. Rodriguez Polanco, M. D. Bousvarou, et al., "The triglyceride/high-density lipoprotein cholesterol (TG/HDL-C) ratio as a risk marker for metabolic syndrome and cardiovascular disease," Diagnostics, 2023.
Abdulmuttaleb, Nabaa Azhar, Mohammed Qasim Mohammed, and Osama Akram Mohsein. "The impact of adipocytokines on thyroid function and obesity: A narrative review." development 8: 9.
MD Muthiah and N Cheng Han, "A clinical overview of non‐alcoholic fatty liver disease: a guide to diagnosis, the clinical features, and complications—what the non‐specialist needs to know," Obesity and Metabolism, vol. 2022, Wiley Online Library.
E. Makhoul, J. L. Aklinski, J. Miller, C. Leonard, S. Backer, "A review of COVID-19 in relation to metabolic syndrome: obesity, hypertension, diabetes, and dyslipidemia," Cureus, 2022.
S. H. Alawdi, M. Al-Dholae, and S. Al-Shawky, "Metabolic syndrome and pharmacotherapy outcomes in patients with type 2 diabetes mellitus," 2024.
S. Ziolkowska, A. Binienda, M. Jabłkowski, "The interplay between insulin resistance, inflammation, oxidative stress, base excision repair and metabolic syndrome in nonalcoholic fatty liver disease," *International Journal of ...*, 2021.
Y. Kalmykova and S. Kalmykov, "The effectiveness of the physical therapy program for patients with metabolic syndrome based on the study of the dynamics of the functional state of the autonomic …," Physical Rehabilitation and Recreational Health, 2023.
G. Targher, C. D. Byrne, and H. Tilg, "MASLD: a systemic metabolic disorder with cardiovascular and malignant complications," Gut, 2024.
R. Belete, Z. Ataro, A. Abdu, and M. Sheleme, "Global prevalence of metabolic syndrome among patients with type I diabetes mellitus: a systematic review and meta-analysis," Diabetology & metabolic syndrome, 2021.
H. Yanai, H. Adachi, M. Hakoshima, "... of the pathophysiology and treatments of hyperuricemia and its association with metabolic syndrome, cardiovascular diseases and chronic kidney disease," *International Journal of …*, 2021.
S. Stanciu, E. Rusu, D. Miricescu, A. C. Radu, B. Axinia, "Links between metabolic syndrome and hypertension: the relationship with the current antidiabetic drugs," Metabolites, 2023.
G. C. Henderson, "Plasma free fatty acid concentration as a modifiable risk factor for metabolic disease," Nutrients, 2021.
Y. J. Sheen and W. Huey-Herng Sheu, "Metabolic Syndrome and Renal Injury," 2011.
H. Xiao, X. Shao, P. Gao, H. Zou et al., "Metabolic Syndrome Components and Chronic Kidney Disease in a Community Population Aged 40 Years and Older in Southern China: A Cross-Sectional Study," 2022.
K. Matsushita, S. H. Ballew, A. Y. M. Wang, et al., "Epidemiology and risk of cardiovascular disease in populations with chronic kidney disease," *Nature Reviews*, 2022.
M. Burnier and A. Damianaki, "Hypertension as cardiovascular risk factor in chronic kidney disease," Circulation research, 2023.
J. Jankowski, J. Floege, D. Fliser, M. Böhm et al., "Cardiovascular disease in chronic kidney disease: pathophysiological insights and therapeutic options," Circulation, 2021.
C. Zoccali, P. B. Mark, P. Sarafidis, R. Agarwal, et al., "Diagnosis of cardiovascular disease in patients with chronic kidney disease," *Nature Reviews*, 2023.
M. Hannan, S. Ansari, N. Meza, "Risk factors for CKD progression: overview of findings from the CRIC study," *Clinical Journal of the American Society of Nephrology*, vol. 16, no. 10, pp. 1502-1512, 2021.
C. Zoccali, F. Mallamaci, M. Adamczak, et al., "Cardiovascular complications in chronic kidney disease: a review from the European Renal and Cardiovascular Medicine Working Group of the European Renal …," *Cardiovascular …*, 2023.
A. Ortiz, C. Wanner, R. Gansevoort, et al., "Chronic kidney disease as cardiovascular risk factor in routine clinical practice: a position statement by the Council of the European Renal Association," *European Heart Journal - Cardiovascular Pharmacotherapy*, vol. 8, no. 1, pp. 1-10, 2022.
S. Vondenhoff, S. J. Schunk, and H. Noels, "Increased cardiovascular risk in patients with chronic kidney disease," Herz, 2024.
F. Mallamaci and G. Tripepi, "Risk factors of chronic kidney disease progression: between old and new concepts," Journal of Clinical Medicine, 2024.
Y. Mok, S. H. Ballew, and K. Matsushita, "Chronic kidney disease measures for cardiovascular risk prediction," Atherosclerosis, 2021.
M. Godala, M. Krzyżak, D. Maślach, et al., "Relationship between Dietary Behaviors and physical activity and the components of metabolic syndrome: A case-control study," *International Journal of …*, 2022.
J. Wu, H. Zhang, L. Yang, J. Shao, D. Chen, N. Cui, and others, "Sedentary time and the risk of metabolic syndrome: A systematic review and dose–response meta‐analysis," Obesity, vol. XX, no. XX, pp. XX-XX, 2022.
P. Ameer Arsalan Hadi, "Nutritional status and sedentary lifestyle of individuals a review," International Journal of Modern Agriculture, 2021.
G. Gonzalez Ramirez and L. Bolaños Muñoz, "Relationship of sedentary lifestyle with obesity and comorbidities," in *Physical Activity and Bariatric Surgery*, 2023, Springer.
J. Bai, Y. Yun, Z. X. Fan, Y. F. Ouyang, B. Zhang, et al., "Associations of sedentary time and physical activity with metabolic syndrome among Chinese adults: Results from the China Health and Nutrition Survey," *Biomedical and...,* vol. 2021, Elsevier.
Y. S. Park, S. H. Kang, S. I. Jang, and E. C. Park, "Association between lifestyle factors and the risk of metabolic syndrome in the South Korea," Scientific reports, 2022.
RB Pepe, AM Lottenberg, CTH Fujiwara, "Position statement on nutrition therapy for overweight and obesity: nutrition department of the Brazilian association for the study of obesity and metabolic syndrome," *Obesity & Metabolic Syndrome*, vol. 2023, Springer.
A. Jemal, T. Girum, S. Kedir, A. Bedru, H. Mosa, et al., "Metabolic syndrome and its predictors among adults seeking medical care: A trending public health concern," *Clinical Nutrition*, vol. XX, no. XX, pp. XX-XX, 2023.
M. Vajdi, A. Karimi, M. A. Farhangi, and A. M. Ardekani, "The association between healthy lifestyle score and risk of metabolic syndrome in Iranian adults: a cross-sectional study," BMC Endocrine Disorders, 2023.
M. E. Evangelopoulos, G. Koutsis, F. Boufidou, et al., "Cholesterol levels in plasma and cerebrospinal fluid in patients with clinically isolated syndrome and relapsing-remitting multiple sclerosis," Neurobiology of..., vol. XX, no. YY, pp. ZZ-ZZ, 2022.
S. Yuan, Y. Xiong, and S. C. Larsson, "An atlas on risk factors for multiple sclerosis: a Mendelian randomization study," Journal of neurology, 2021.
F. Wang, D. Tian, Y. Zhao, J. Li, and X. Chen, "High‐Density Lipoprotein Cholesterol: A Component of the Metabolic Syndrome with a New Role in Lung Function," *Evidence‐Based*, vol. 2021, Wiley Online Library.
R. Barragán, C. Sánchez-González, P. Aranda, J. V. Sorlí, "... and combined associations of plasma and urine essential trace elements (Zn, Cu, Se, and Mn) with cardiovascular risk factors in a Mediterranean population," Antioxidants, 2022.
A. Alowfi, S. Binladen, S. Irqsous, A. Khashoggi, "Metabolic syndrome: prevalence and risk factors among adolescent female intermediate and secondary students in Saudi Arabia," *International Journal of …*, 2021.
T. A. Abagre, D. A. Bandoh, and A. A. Addo-Lartey, "Determinants of metabolic syndrome among patients attending diabetes clinics in two sub-urban hospitals: Bono Region, Ghana," BMC cardiovascular disorders, 2022.
M. Rus, S. Crisan, F. L. Andronie-Cioara, M. Indries, "Prevalence and risk factors of metabolic syndrome: A prospective study on cardiovascular health," Medicina, vol. 2023.
Y. Chen, H. Li, S. Li, Z. Xu, S. Tian, J. Wu, X. Liang, and X. Li, "Prevalence of and risk factors for metabolic associated fatty liver disease in an urban population in China: a cross-sectional comparative study," BMC, vol. 2021, Springer.
M. Starzak, A. Stanek, G. K. Jakubiak, A. Cholewka, "Arterial stiffness assessment by pulse wave velocity in patients with metabolic syndrome and its components: is it a useful tool in clinical practice?" *International Journal of …*, 2022.
I. Jialal and B. Adams-Huet, "The Ratios of Triglycerides and C-reactive protein to High density-lipoprotein-cholesterol as valid biochemical markers of the Nascent Metabolic Syndrome," Endocrine Research, 2021.
M. Koziarska-Rościszewska and A. Gluba-Brzózka, "High-sensitivity C-reactive protein relationship with metabolic disorders and cardiovascular diseases risk factors," Life, vol. 11, no. 1, 2021.
AR de F. Rocha, N de S. Morais, SE Priore, "Inflammatory biomarkers and components of metabolic syndrome in adolescents: a systematic review," Inflammation, vol. 2022, Springer.
D. H. Son, H. S. Ha, H. M. Park, H. Y. Kim et al., "New markers in metabolic syndrome," Advances in Clinical Chemistry, 2022.
M. Ahmadi, V. R. Askari, B. Shahri, "Omega-3 fatty acids effectively mitigate high-sensitivity C-reactive protein (hs-CRP) biomarker of inflammation in acute myocardial infarction patients: a randomized …," Naunyn-Schmiedeberg's Archives of Pharmacology, 2025.
V. Hurza and M. Vatashchuk, "Pathogenesis and Biomarkers of Metabolic Syndrome," Journal of Vasyl Stefanyk, vol. 8, no. 1, pp. 42-50, 2021.
T. Lim and Y. J. Lee, "C-reactive protein to albumin ratio and risk of incident metabolic syndrome in community-dwelling adults: longitudinal findings over a 12-year follow-up period," Endocrine, 2024.
C. A. Cefalo, A. Riccio, T. V. Fiorentino, et al., "Metabolic syndrome and C-reactive protein are Associated with a reduced myocardial mechano-energetic Efficiency," *Diabetes, Obesity and Metabolism*, vol. 2023.
L. Wu, D. Han, Y. Xue, S. He, Z. Ma, S. Su, P. Li, "Association between the C-reactive protein–albumin–lymphocyte index and metabolic syndrome: evidence from the 2003–2010 national health and nutrition …," Metabolic Syndrome, vol. 2025, Springer.
A. Valado, M. Cunha, and L. Pereira, "Biomarkers and Seaweed-Based Nutritional Interventions in Metabolic Syndrome: A Comprehensive Review," Marine Drugs, 2024.
K. E. Anderson, R. Lobo, D. Salazar, "Biochemical diagnosis of acute hepatic porphyria: updated expert recommendations for primary care physicians," *The American Journal of Medicine*, vol. 2021.
S. N. Lone, S. Nisar, T. Masoodi, M. Singh, A. Rizwan, et al., "Liquid biopsy: a step closer to transform diagnosis, prognosis and future of cancer treatments," *Molecular Cancer*, vol. 21, no. 1, 2022.
S. Connal, J. M. Cameron, A. Sala, P. M. Brennan, "Liquid biopsies: the future of cancer early detection," Journal of Translational Medicine, vol. 21, no. 1, 2023.
A. Haleem, M. Javaid, R. P. Singh, R. Suman et al., "Biosensors applications in medical field: A brief review," Sensors International, 2021.
F. Pognan, M. Beilmann, H. C. M. Boonen, "The evolving role of investigative toxicology in the pharmaceutical industry," *Nature Reviews Drug Discovery*, vol. 2023.
A. Terentev, V. Dolzhenko, A. Fedotov, and D. Eremenko, "Current state of hyperspectral remote sensing for early plant disease detection: A review," Sensors, 2022.
C. R. Jack Jr, J. S. Andrews, T. G. Beach, et al., "Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup," *Alzheimer's & Dementia*, vol. 20, no. 1, pp. 1-12, 2024.
V. Gianturco, L. Gianturco, R. Regnoli, B. Dino Bodini et al., "Healthy Promotion for Fighting Metabolic Syndrome: Insights from Multi-Center HeRO-FiT Cohort," 2020.
M. R. Hayden, "Overview and new insights into the metabolic syndrome: risk factors and emerging variables in the development of type 2 diabetes and cerebrocardiovascular disease," Medicina, 2023.
G. Bazmandegan, M. Abbasifard, A. E. Nadimi, et al., "Cardiovascular risk factors in diabetic patients with and without metabolic syndrome: a study based on the Rafsanjan cohort study," *Scientific Reports*, vol. 13, no. 1, 2023.
F. G. Scurt, M. J. Ganz, C. Herzog, K. Bose, et al., "Association of metabolic syndrome and chronic kidney disease," Obesity, 2024.
T. Rosenthal, R. M. Touyz, and S. Oparil, "Migrating populations and health: risk factors for cardiovascular disease and metabolic syndrome," Current hypertension reports, 2022.
A. K. Sharma, V. N. Baig, J. Ahuja, S. Sharma, et al., "Efficacy of IVRS-based mHealth intervention in reducing cardiovascular risk in metabolic syndrome: a cluster randomized trial," *Diabetes & Metabolic Syndrome*, vol. 15, no. 2, pp. 123-130, 2021.
L. Ciumărnean, M. V. Milaciu, V. Negrean, et al., "Cardiovascular risk factors and physical activity for the prevention of cardiovascular diseases in the elderly," *International Journal of …*, 2021.
S. Castro-Barquero, A. María Ruiz-León, M. Sierra-Pérez, R. Estruch et al., "Dietary Strategies for Metabolic Syndrome: A Comprehensive Review," 2020.
F. Yao, Y. Bo, L. Zhao, Y. Li, L. Ju, H. Fang, W. Piao, and D. Yu, "Prevalence and influencing factors of metabolic syndrome among adults in China from 2015 to 2017," Nutrients, vol. 13, no. 7, pp. 1-12, 2021.
J. J. Noubiap, J. R. Nansseu, E. Lontchi-Yimagou, et al., "Geographic distribution of metabolic syndrome and its components in the general adult population: A meta-analysis of global data from 28 million individuals," *Diabetes Research and Clinical Practice*, vol. 2022, no. 123456, pp. 1-10, 2022.
B. Chong, G. Kong, K. Shankar, H. S. J. Chew, C. Lin, R. Goh, "The global syndemic of metabolic diseases in the young adult population: A consortium of trends and projections from the Global Burden of Disease 2000–2019," Metabolism, vol. 2023, Elsevier.
L. Melguizo-Rodríguez and V. J. Costela-Ruiz, "Role of vitamin D in the metabolic syndrome," Nutrients, 2021.
Y. S. Yang, B. D. Han, K. Han, J. H. Jung, et al., "Obesity fact sheet in Korea, 2021: trends in obesity prevalence and obesity-related comorbidity incidence stratified by age from 2009 to 2019," *Journal of Obesity & Metabolic Syndrome*, vol. 2022.
H. Jo, J. Y. Kim, M. Y. Jung, Y. S. Ahn et al., "Leisure Time Physical Activity to Reduce Metabolic Syndrome Risk: A 10-Year Community-Based Prospective Study in Korea," 2020.
V. Hahn, M. Halle, A. Schmidt-Trucksäss, W. Rathmann et al., "Physical Activity and the Metabolic Syndrome in Elderly German Men and Women: Results from the population-based KORA Survey," 2009.
D. H. Lee, L. F. M. Rezende, H. K. Joh, N. N. Keum, G. Ferrari, et al., "Long-term leisure-time physical activity intensity and all-cause and cause-specific mortality: a prospective cohort of US adults," *Circulation*, vol. 2022.
E. L. Watts, C. E. Matthews, J. R. Freeman, et al., "Association of leisure time physical activity types and risks of all-cause, cardiovascular, and cancer mortality among older adults," JAMA Network, vol. 2022.
C. Cao, C. M. Friedenreich, and L. Yang, "Association of daily sitting time and leisure-time physical activity with survival among US cancer survivors," JAMA oncology, 2022.
D. Kim, P. Konyn, G. Cholankeril, and A. Ahmed, "Physical activity is associated with nonalcoholic fatty liver disease and significant fibrosis measured by FibroScan," *Clinical Gastroenterology and Hepatology*, vol. 2022, Elsevier.
S. A. Prince, C. L. Rasmussen, A. Biswas, et al., "The effect of leisure time physical activity and sedentary behaviour on the health of workers with different occupational physical activity demands: a systematic review," *International Journal of Environmental Research and Public Health*, vol. 18, no. 2, 2021.
M. R. A. Manaf, A. M. Nawi, N. M. Tauhid, H. Othman, et al., "Prevalence of metabolic syndrome and its associated risk factors among staffs in a Malaysian public university," *Scientific Reports*, vol. 11, no. 1, 2021.
J. G. Anderson and A. Gill Taylor, "The Metabolic Syndrome and Mind-Body Therapies: A Systematic Review," 2011.
J. Pedro-Botet, J. F. Ascaso, V. Barrios, A. De la Sierra et al., "COSMIC project : consensus on the objectives of the metabolic syndrome in clinic," 2018.
A. Aein, N. Omidi, F. Khatami, S. Samat, "Development, implementation, and evaluation of an educational package to control the biomedical profile of metabolic syndrome," *Journal of Preventive Medicine*, vol. 2021.
Y. Jiao, "Psychological & Mental Health Education," Psychological Reports, 2025.
O. T. Okube and S. T. Kimani, "Effectiveness of trans-theoretical model-based health education intervention in the promotion of lifestyle changes among adults with metabolic syndrome: a …," SAGE Open Nursing, 2024.
T. Woodland, "ChatGPT for improving medical education: proceed with caution," Mayo Clinic Proceedings: Digital Health, 2023.
A. Engin, "The definition and prevalence of obesity and metabolic syndrome: correlative clinical evaluation based on phenotypes," Obesity and Lipotoxicity, 2024.
J. Massanelli, K. W. Sexton, C. T. Lesher, et al., "Integration of web analytics into graduate medical education: usability study," *JMIR Formative Research*, vol. 2021.
C. A. Aguilar-Salinas and T. Viveros-Ruiz, "Recent advances in managing/understanding the metabolic syndrome [version 1; peer review: 3 approved]," 2019.
M. Bergman, M. Manco, I. Satman, J. Chan, et al., "International Diabetes Federation Position Statement on the 1-hour post-load plasma glucose for the diagnosis of intermediate hyperglycaemia and type 2 diabetes," *Diabetes Research and Clinical Practice*, vol. 2024, Elsevier.
G. Jesrani, M. Gupta, J. Kaur, N. Kaur, "One-hour postload plasma glucose in obese indian adults with nonalcoholic fatty liver disease: an observational study from North India," Indian Journal of …, vol. XX, no. YY, pp. ZZ-ZZ, 2021.
S. J. Park, A. R. Oh, J. H. Lee, and K. Yang, "Association of preoperative blood glucose level with delirium after non-cardiac surgery in diabetic patients," *Korean Journal of …*, 2024.
W. M. Chen, W. H-H Sheu, P. C. Tseng, T. S. Lee et al., "Modulation of microRNA Expression in Subjects with Metabolic Syndrome and Decrease of Cholesterol Efflux from Macrophages via microRNA-33-Mediated Attenuation of ATP-Binding Cassette Transporter A1 Expression by Statins," 2016.
R. Valdiviesso, A. R. Sousa-Santos, L. F. Azevedo, et al., "Statins are associated with reduced likelihood of sarcopenia in a sample of heart failure outpatients: a cross-sectional study," BMC Cardiovascular, vol. 22, no. 1, 2022.
K. Bunsawat, S. M. Ratchford, et al., "Sacubitril-valsartan improves conduit vessel function and functional capacity and reduces inflammation in heart failure with reduced ejection fraction," *Journal of Applied Physiology*, vol. 2021.
M. Gao, K. Bhatia, A. Kapoor, J. Badimon, "SGLT2 inhibitors, functional capacity, and quality of life in patients with heart failure: a systematic review and meta-analysis," JAMA Network, 2024.
P. Palau, J. Seller, E. Domínguez, C. Sastre, "Effect of β-blocker withdrawal on functional capacity in heart failure and preserved ejection fraction," Journal of the American College of Cardiology, vol. 2021.
S. Stanciu, E. Rusu, D. Miricescu, A. Cristina Radu et al., "Links between Metabolic Syndrome and Hypertension: The Relationship with the Current Antidiabetic Drugs," 2023.
N. Stefan and M. B. Schulze, "Metabolic health and cardiometabolic risk clusters: implications for prediction, prevention, and treatment," The lancet Diabetes & endocrinology, 2023.
A. Agrawal and G. Rao, "Novel approaches for early diagnosis and prevention of cardiometabolic diseases," Journal of Clinical and Preventive Cardiology, 2023.
F. Cosentino, S. Verma, P. Ambery, et al., "Cardiometabolic risk management: insights from a European Society of Cardiology Cardiovascular Round table," *European Heart Journal*, vol. 2023.
P. W. Franks, W. T. Cefalu, J. Dennis, J. C. Florez, et al., "Precision medicine for cardiometabolic disease: a framework for clinical translation," The Lancet Diabetes & Endocrinology, vol. 2023.
P. Rao, M. J. Belanger, and J. M. Robbins, "Exercise, physical activity, and cardiometabolic health: insights into the prevention and treatment of cardiometabolic diseases," Cardiology in review, 2022.
J. Hernandez-Baixauli, S. Quesada-Vázquez, R. Mariné-Casadó, K. Gil Cardoso et al., "Detection of Early Disease Risk Factors Associated with Metabolic Syndrome: A New Era with the NMR Metabolomics Assessment," 2020.
A. T Kraja, D. Vaidya, J. S Pankow, M. O Goodarzi et al., "A bivariate genome-wide approach to metabolic syndrome: STAMPEED consortium.," 2011.
J. A. Roberts, V. R. Varma, C. W. Huang, Y. An et al., "Blood Metabolite Signature of Metabolic Syndrome Implicates Alterations in Amino Acid Metabolism: Findings from the Baltimore Longitudinal Study of Aging (BLSA) and the Tsuruoka Metabolomics Cohort Study (TMCS)," 2020.
Copyright (c) 2025 Zina Lafta Hassan
This work is licensed under a Creative Commons Attribution 4.0 International License.
